PMM2-CDG

Clinical trials for PMM2-CDG explained in plain language.

Never miss a new study

Get alerted when new PMM2-CDG trials appear

Sign up with your email to follow new studies for PMM2-CDG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 2 Completed 1 Terminated 1

New drug shows promise for rare childhood disorder

Disease control Completed

This study tested an experimental drug called GLM101 in 27 people with PMM2-CDG, a rare genetic condition that affects movement and development. Participants received different doses of the drug intravenously over 24 weeks. The main goal was to see if the drug improves coordinati…

Matched conditions: PMM2-CDG

Phase: PHASE2 • Sponsor: Glycomine, Inc. • Aim: Disease control

Last updated Apr 26, 2026 20:01 UTC

PMM2-CDG

Get alerted when new PMM2-CDG trials appear

New drug shows promise for rare childhood disorder